First Trust Advisors LP Boosts Holdings in Xylem Inc. $XYL

First Trust Advisors LP lifted its stake in Xylem Inc. (NYSE:XYLFree Report) by 2.9% in the first quarter, HoldingsChannel.com reports. The fund owned 678,971 shares of the industrial products company’s stock after purchasing an additional 18,933 shares during the period. First Trust Advisors LP’s holdings in Xylem were worth $81,137,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently made changes to their positions in the company. Commonwealth Retirement Investments LLC bought a new position in shares of Xylem in the fourth quarter worth about $27,000. Wexford Capital LP bought a new stake in Xylem in the 3rd quarter worth approximately $27,000. Global Assets Advisory LLC purchased a new stake in shares of Xylem during the 1st quarter valued at about $40,000. FWL Investment Management LLC bought a new stake in Xylem in the second quarter worth $43,000. Finally, Entrust Financial LLC bought a new stake in shares of Xylem in the 4th quarter worth about $45,000. 87.96% of the stock is currently owned by institutional investors.

Insider Activity at Xylem

In related news, Director Jerome A. Peribere bought 1,210 shares of the company’s stock in a transaction on Monday, May 4th. The stock was bought at an average cost of $116.61 per share, for a total transaction of $141,098.10. Following the acquisition, the director directly owned 27,209 shares in the company, valued at $3,172,841.49. This represents a 4.65% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CAO Geri-Michelle Mcshane sold 4,269 shares of the firm’s stock in a transaction on Thursday, May 7th. The stock was sold at an average price of $117.46, for a total value of $501,436.74. Following the completion of the sale, the chief accounting officer directly owned 3,605 shares of the company’s stock, valued at $423,443.30. This trade represents a 54.22% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 0.32% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on the company. Oppenheimer dropped their price objective on Xylem from $160.00 to $158.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 29th. Royal Bank Of Canada lifted their target price on Xylem from $157.00 to $159.00 and gave the stock an “outperform” rating in a report on Thursday, July 16th. Stifel Nicolaus decreased their price objective on shares of Xylem from $159.00 to $157.00 and set a “buy” rating for the company in a research note on Monday. JPMorgan Chase & Co. cut their price objective on shares of Xylem from $170.00 to $160.00 and set an “overweight” rating on the stock in a research note on Thursday, April 16th. Finally, UBS Group raised their target price on shares of Xylem from $132.00 to $133.00 and gave the stock a “neutral” rating in a report on Wednesday, April 29th. Eight investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Xylem currently has an average rating of “Moderate Buy” and an average price target of $153.15.

Check Out Our Latest Stock Analysis on XYL

Xylem Price Performance

Shares of Xylem stock opened at $119.66 on Friday. The business has a 50 day simple moving average of $114.04 and a two-hundred day simple moving average of $122.82. Xylem Inc. has a 12 month low of $105.29 and a 12 month high of $154.27. The stock has a market capitalization of $28.44 billion, a P/E ratio of 29.77, a PEG ratio of 1.66 and a beta of 1.03. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.46 and a quick ratio of 1.10.

Xylem (NYSE:XYLGet Free Report) last announced its quarterly earnings data on Tuesday, April 28th. The industrial products company reported $1.12 earnings per share for the quarter, beating analysts’ consensus estimates of $1.09 by $0.03. The company had revenue of $2.12 billion for the quarter, compared to analyst estimates of $2.11 billion. Xylem had a return on equity of 11.26% and a net margin of 10.79%.The firm’s revenue for the quarter was up 2.7% on a year-over-year basis. During the same quarter last year, the firm posted $1.03 EPS. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. As a group, analysts predict that Xylem Inc. will post 5.52 EPS for the current fiscal year.

Xylem Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, June 25th. Investors of record on Thursday, May 28th were issued a $0.43 dividend. This represents a $1.72 annualized dividend and a dividend yield of 1.4%. The ex-dividend date of this dividend was Thursday, May 28th. Xylem’s dividend payout ratio (DPR) is currently 42.79%.

About Xylem

(Free Report)

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.

Recommended Stories

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYLFree Report).

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.